Europe Pharmaceutical Contract Development and Manufacturing Organization (CDMO) Market

1
Europe Pharmaceutical Contract Development and
Manufacturing Organization (CDMO) Market to Grow
on the Back of Increasing Prevalence of Chronic
Diseases Market to Grow with a CAGR of 6.7
during 2021-2030 Kenneth Research has released
a report titled Europe Pharmaceutical Contract
Development and Manufacturing Organization (CDMO)
Market Demand Analysis Opportunity Outlook
2030 which also includes some of the prominent
market analyzing parameters such as industry
growth drivers, restraints, supply and demand
risk, along with the impact of COVID-19 and a
detailed discussion on the latest trends and
future opportunities that are associated with
the growth of the market. In one of the
statistics by the European Commission, there were
1.68 Million deaths in the European Union, in
the year 2018, due to the diseases of the
circulatory system. Additionally, the World
Health Organization (WHO), stated that in the
same region, about 60 Million people above the
age of 25 years were known to have
diabetes. Download Sample Reports Here -
https//www.kennethresearch.com/sample-request-103
52351 The statistics portray the growing
prevalence of chronic diseases in Europe, which
is driving the need amongst the pharmaceutical
drug manufacturers to develop advanced
pharmaceutical drugs to treat these diseases.
Modern medicines require active pharmaceutical
ingredients for the production of
2
these drugs, which is expected to drive the
growth of the Europe pharmaceutical contract
development and manufacturing organization
(CDMO) market in the coming years. Additionally,
increasing need for research and developments in
the field of medical sciences, along with the
presence of numerous pharmaceutical drug
manufacturers in the region, are some of the
factors anticipated to create numerous
opportunities for market growth in the coming
years. The Europe pharmaceutical contract
development and manufacturing organization
(CDMO) market is anticipated to grow with a CAGR
of 6.7 during the forecast period, i.e.,
2021-2030. The market is estimated to garner a
revenue of USD 39920.2 Million by the end of
2030. Moreover, in the year 2020, the market in
the nation generated a revenue of USD 21133.3
Million. The market is segmented by end-user
into pharmaceutical biopharmaceutical
companies, medical device companies, and academic
institutes. By the end of 2030, the
pharmaceutical biopharmaceutical companies
segment is anticipated to garner the largest
revenue of USD 27756.1 Million, up from a
revenue of USD 14771.1 Million in the year
2020. By country, the Europe pharmaceutical
contract development and manufacturing
organization (CDMO) market is segmented into
Germany, United Kingdom, France, Italy, Spain,
Russia, and the Rest of Europe, out of which,
the market in Italy is anticipated to garner the
largest revenue of USD 8942.1 Million by the end
of 2030, up from a revenue of USD 4860.7 Million
in the year 2020.
3
However, the stringent government regulations,
and the loss of intellectual property are some
of the major factors predicted to hinder the
market growth in the coming years. This report
also provides the existing competitive scenario
of some of the key players of the Europe
pharmaceutical contract development and
manufacturing organization (CDMO) market, which
includes company profiling of Hangzhou Tigermed
Consulting Co., Ltd, ICON plc, IQVIA Inc., LSK
Global Pharma Services Co., Ltd., Parexel
International Corporation, PPD Inc., Almac
Group, Quanticate International Limited, Samsung
Biologics, Syneos Health, Wuxi Apptec Co., Ltd.,
Delpharm Holding, Evonik Industries AG,
Siegfried Holding AG, Aenova Group, Baxter
International, Inc., Boehringer Ingelheim
International GmbH, Catalent, Inc., Famar Group,
Jubilant Pharmova Limited, Lonza, CMIC HOLDINGS
Co., LTD., Labcorp Drug Development, Thermo
Fisher Scientific Inc., Pfizer Inc., Recipharm
AB, Vetter Pharma-Fertigung GmbH Co. KG,
Charles River Laboratories International, Inc.,
and others. The profiling enfolds key
information of the companies which comprises of
business overview, products and services, key
financials and recent news and developments.
Conclusively, the report titled Europe
Pharmaceutical Contract Development and
Manufacturing Organization (CDMO) Market Demand
Analysis Opportunity Outlook 2030, analyses
the overall Europe pharmaceutical contract
development and manufacturing organization
(CDMO) industry to help new entrants to
understand the details of the market. In
addition to that, this report also guides existing
4
players looking for expansion and major investors
looking for investment in the Europe
pharmaceutical contract development and
manufacturing organization (CDMO) market in the
near future. Request Report Sample -
https//www.kennethresearch.com/sample-request-103
52351 Kenneth Research is a leading service
provider for strategic market research and
consulting. We aim to provide unbiased,
unparalleled market insights and industry
analysis to help industries, conglomerates and
executives to take wise decisions for their
future marketing strategy, expansion and
investment, etc. We believe every business can
expand to its new horizon, provided a right
guidance at a right time is available through
strategic minds. Our out of box thinking helps
our clients to take wise decision so as to avoid
future uncertainties.
Contact for more Info AJ Daniel Email
sales_at_kennethresearch.com U.S. Phone [phone]
0609